About
Small Molecules, Peptide
Areas of Focus
Categories
Small Molecule PharmaceuticalGene Therapy, RNA & Peptide TherapySan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
3,024
By Phase
PHASE1/PHASE2: 1PHASE1: 1NA: 1
By Status
UNKNOWN: 2TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05716295Lead Sponsor
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Terminated
26 participants
Started: Feb 8, 2023 · Completed: Apr 30, 2024
NCT05366634Lead Sponsor
A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers
PHASE1Completed
26 participants
Started: Jun 30, 2022 · Completed: Dec 28, 2022
NCT03834207Collaborator
A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy
NAUnknown
672 participants
Started: Oct 1, 2018 · Completed: Apr 30, 2020
NCT02838693Lead Sponsor
Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
N/AUnknown
2,300 participants
Started: Mar 31, 2016 · Completed: Dec 31, 2021
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...